QuilliChew ER 30 mg/1

QuilliChew ER 30 mg chewable tablets provide extended-release methylphenidate hydrochloride for oral use. This medication is commonly used to manage ADHD symptoms in patients who prefer a chewable form. Learn more about its uses and effects.

QuilliChew ER 30 mg chewable tablets contain methylphenidate hydrochloride, a central nervous system stimulant. What is QuilliChew ER used for? It is primarily prescribed to help manage symptoms of attention deficit hyperactivity disorder (ADHD) in patients who require an extended-release formulation. The chewable form is designed for those who have difficulty swallowing traditional tablets.

Common effects of QuilliChew ER 30 mg may include increased alertness and focus, which are typical of stimulant medications. Some users may experience mild side effects such as decreased appetite or trouble sleeping. These effects can vary among individuals and should be discussed with a healthcare provider.

QuilliChew ER 30 mg should be handled with care, especially by individuals with a history of heart conditions or high blood pressure. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always store the medication in a safe place, out of reach of children.

QuilliChew ER 30 mg may interact with certain medications, including other stimulants, antidepressants, and some over-the-counter cold or allergy medications. Alcohol and other substances that affect the central nervous system should be avoided while taking this medication. Always inform your healthcare provider about all medications you are taking.